(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.76% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.77%.
Neogen's revenue in 2026 is $870,400,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $192,218,558,664, with the lowest NEOG revenue forecast at $180,657,228,696, and the highest NEOG revenue forecast at $201,965,662,579. On average, 6 Wall Street analysts forecast NEOG's revenue for 2028 to be $194,436,188,347, with the lowest NEOG revenue forecast at $180,960,326,558, and the highest NEOG revenue forecast at $207,918,591,816.
In 2029, NEOG is forecast to generate $179,957,268,884 in revenue, with the lowest revenue forecast at $172,900,976,207 and the highest revenue forecast at $185,251,668,953.